IBDEI0GL ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7392,0)
 ;;=96360^^51^491^1^^^^1
 ;;^UTILITY(U,$J,358.3,7392,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7392,1,2,0)
 ;;=2^96360
 ;;^UTILITY(U,$J,358.3,7392,1,3,0)
 ;;=3^IV INF,HYDRATION,31-60 MIN
 ;;^UTILITY(U,$J,358.3,7393,0)
 ;;=96361^^51^491^2^^^^1
 ;;^UTILITY(U,$J,358.3,7393,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7393,1,2,0)
 ;;=2^96361
 ;;^UTILITY(U,$J,358.3,7393,1,3,0)
 ;;=3^IV INF,HYDRATION,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,7394,0)
 ;;=96365^^51^491^3^^^^1
 ;;^UTILITY(U,$J,358.3,7394,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7394,1,2,0)
 ;;=2^96365
 ;;^UTILITY(U,$J,358.3,7394,1,3,0)
 ;;=3^IV INF,THER/PROPH,UP TO 1 HR
 ;;^UTILITY(U,$J,358.3,7395,0)
 ;;=96366^^51^491^4^^^^1
 ;;^UTILITY(U,$J,358.3,7395,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7395,1,2,0)
 ;;=2^96366
 ;;^UTILITY(U,$J,358.3,7395,1,3,0)
 ;;=3^IV INF,THER/PROPH,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,7396,0)
 ;;=96374^^51^491^5^^^^1
 ;;^UTILITY(U,$J,358.3,7396,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7396,1,2,0)
 ;;=2^96374
 ;;^UTILITY(U,$J,358.3,7396,1,3,0)
 ;;=3^IV PUSH,SINGLE/INIT SUBS/DRUG
 ;;^UTILITY(U,$J,358.3,7397,0)
 ;;=96375^^51^491^6^^^^1
 ;;^UTILITY(U,$J,358.3,7397,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7397,1,2,0)
 ;;=2^96375
 ;;^UTILITY(U,$J,358.3,7397,1,3,0)
 ;;=3^IV PUSH,EA SUBSQUENT PUSH
 ;;^UTILITY(U,$J,358.3,7398,0)
 ;;=S9445^^51^492^1^^^^1
 ;;^UTILITY(U,$J,358.3,7398,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7398,1,2,0)
 ;;=2^S9445
 ;;^UTILITY(U,$J,358.3,7398,1,3,0)
 ;;=3^PT EDUCATION INDIVID NON-MD
 ;;^UTILITY(U,$J,358.3,7399,0)
 ;;=99071^^51^492^2^^^^1
 ;;^UTILITY(U,$J,358.3,7399,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7399,1,2,0)
 ;;=2^99071
 ;;^UTILITY(U,$J,358.3,7399,1,3,0)
 ;;=3^PATIENT EDUCATION MATERIALS
 ;;^UTILITY(U,$J,358.3,7400,0)
 ;;=0505F^^51^493^1^^^^1
 ;;^UTILITY(U,$J,358.3,7400,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7400,1,2,0)
 ;;=2^0505F
 ;;^UTILITY(U,$J,358.3,7400,1,3,0)
 ;;=3^HEMODIALYSIS PLAN DOCD
 ;;^UTILITY(U,$J,358.3,7401,0)
 ;;=B4164^^51^494^7^^^^1
 ;;^UTILITY(U,$J,358.3,7401,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7401,1,2,0)
 ;;=2^B4164
 ;;^UTILITY(U,$J,358.3,7401,1,3,0)
 ;;=3^ENTERAL FORMULA, CAT IV
 ;;^UTILITY(U,$J,358.3,7402,0)
 ;;=A4730^^51^494^8^^^^1
 ;;^UTILITY(U,$J,358.3,7402,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7402,1,2,0)
 ;;=2^A4730
 ;;^UTILITY(U,$J,358.3,7402,1,3,0)
 ;;=3^FISTULA CANNULATION SET, EA
 ;;^UTILITY(U,$J,358.3,7403,0)
 ;;=B5000^^51^494^10^^^^1
 ;;^UTILITY(U,$J,358.3,7403,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7403,1,2,0)
 ;;=2^B5000
 ;;^UTILITY(U,$J,358.3,7403,1,3,0)
 ;;=3^PARENT NUT SOL,ANY STRTH,RENAL
 ;;^UTILITY(U,$J,358.3,7404,0)
 ;;=A4714^^51^494^12^^^^1
 ;;^UTILITY(U,$J,358.3,7404,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7404,1,2,0)
 ;;=2^A4714
 ;;^UTILITY(U,$J,358.3,7404,1,3,0)
 ;;=3^TREATED WATER PER GALLON
 ;;^UTILITY(U,$J,358.3,7405,0)
 ;;=C1752^^51^494^5^^^^1
 ;;^UTILITY(U,$J,358.3,7405,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7405,1,2,0)
 ;;=2^C1752
 ;;^UTILITY(U,$J,358.3,7405,1,3,0)
 ;;=3^CATH,HEMODIALYSIS,SHORT-TERM
 ;;^UTILITY(U,$J,358.3,7406,0)
 ;;=C1750^^51^494^4^^^^1
 ;;^UTILITY(U,$J,358.3,7406,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7406,1,2,0)
 ;;=2^C1750
 ;;^UTILITY(U,$J,358.3,7406,1,3,0)
 ;;=3^CATH, HEMODIALYSIS,LONG-TERM
 ;;^UTILITY(U,$J,358.3,7407,0)
 ;;=85302^^51^494^3^^^^1
 ;;^UTILITY(U,$J,358.3,7407,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7407,1,2,0)
 ;;=2^85302
 ;;^UTILITY(U,$J,358.3,7407,1,3,0)
 ;;=3^BLOOD CLOT INHIBITOR ANTIGEN
